FRANCISCO DE PAULA
TELLEZ PEREZ
Profesor asociado de Ciencias de la Salud
Hospital General Universitario de Valencia
Valencia, EspañaPublications en collaboration avec des chercheurs de Hospital General Universitario de Valencia (13)
2021
-
Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy
Journal of Hepatology, Vol. 74, Núm. 4, pp. 801-810
2020
-
Executive summary: Consensus document of GEHEP of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), along with SOCIDROGALCOHOL, SEPD and SOMAPA on hepatitis C virus infection management in drug users
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 3, pp. 127-131
-
Impact of HIV on the survival of hepatocellular carcinoma in hepatitis C virus-infected patients
AIDS (London, England), Vol. 34, Núm. 10, pp. 1497-1507
2019
-
High efficacy of resistance-guided retreatment of HCV patients failing NS5A inhibitors in the real world
Journal of Hepatology, Vol. 71, Núm. 5, pp. 876-888
-
Increasing importance of european lineages in seeding the hepatitis C virus subtype 1a epidemic in Spain
Eurosurveillance, Vol. 24, Núm. 9
-
Low performance of ultrasound surveillance for the diagnosis of hepatocellular carcinoma in HIV-infected patients
AIDS, Vol. 33, Núm. 2, pp. 269-278
-
Prevalence of resistance associated substitutions and efficacy of baseline resistance-guided chronic hepatitis C treatment in Spain from the GEHEP-004 cohort
PLoS ONE, Vol. 14, Núm. 8
2018
-
Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/hepatitis C virus-coinfected patients
AIDS, Vol. 32, Núm. 11, pp. 1423-1430
2017
-
Real-life experience with sorafenib for the treatment of hepatocellular carcinoma in HIV-infected patients
AIDS, Vol. 31, Núm. 1, pp. 89-95
-
Week 4 response predicts sustained virological response to all-oral direct-acting antiviral-based therapy in cirrhotic patients with hepatitis C virus genotype 3 infection
Clinical Microbiology and Infection, Vol. 23, Núm. 6, pp. 409.e5-409.e8
2013
-
Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patients
AIDS, Vol. 27, Núm. 16, pp. 2541-2549
-
Risk of liver decompensation among HIV/Hepatitis C virus-coinfected individuals with advanced fibrosis: Implications for the timing of therapy
Clinical Infectious Diseases, Vol. 57, Núm. 10, pp. 1401-1408
2010
-
Concomitant nevirapine therapy is associated with higher efficacy of pegylated interferon plus ribavirin among HIV/ hepatitis C Virus-Coinfected patients
Journal of AIDS and Clinical Research, Vol. 1, Núm. 3